Skip to main content

Peer Review reports

From: A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

Original Submission
6 Oct 2022 Submitted Original manuscript
7 Nov 2022 Reviewed Reviewer Report - Kirsty Loudon
20 Feb 2023 Author responded Author comments - Mark Edward McClure
Resubmission - Version 2
20 Feb 2023 Submitted Manuscript version 2
1 Mar 2023 Author responded Author comments - Mark Edward McClure
Resubmission - Version 3
1 Mar 2023 Submitted Manuscript version 3
Publishing
3 Mar 2023 Editorially accepted
11 Mar 2023 Article published 10.1186/s13063-023-07218-y

You can find further information about peer review here.

Back to article page